An exploratory, multi-center, open-label, single-arm study to evaluate the discontinuation effect of clopidogrel after drug eluting stent (DECADES) on inflammatory and platelet activation markers in subjects who are receiving low dose acetylsalicylic acid (ASA).

Trial Profile

An exploratory, multi-center, open-label, single-arm study to evaluate the discontinuation effect of clopidogrel after drug eluting stent (DECADES) on inflammatory and platelet activation markers in subjects who are receiving low dose acetylsalicylic acid (ASA).

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2012

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions; Biomarker; Pharmacodynamics
  • Acronyms DECADES
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 01 Apr 2009 Sanofi-Aventis added as trial sponsor as reported by ClinicalTrials.gov.
    • 14 Jul 2008 Actual patient number added (101) as reported by ClinicalTrials.gov.
    • 14 Jul 2008 Actual end date added (Jun 2008) as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top